📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
2
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
42%
🔄 Reverse Split
55%
• 50-day avg $0.03 below $1 exchange minimum
📉 Score Deterioration
50%
• Score rose 47 points recently (worsening)
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$23.20M
Shares Outstanding686.43M
Float668.77M
Cash$26.1K
Debt$580.1K
Short InterestN/A
🏛 Institutional Holdings
0.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short interest data updating...
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Sep 30, 2025
xbrl
XBRL WARRANT
Sep 30, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for KAYS
📊 KAYS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 KAYS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.